Last reviewed · How we verify
Dexmedetomidine Hydrochloride Nasal Spray — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Dexmedetomidine Hydrochloride Nasal Spray (Dexmedetomidine Hydrochloride Nasal Spray) — Shanghai Hengrui Pharmaceutical Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Dexmedetomidine Hydrochloride Nasal Spray TARGET | Dexmedetomidine Hydrochloride Nasal Spray | Shanghai Hengrui Pharmaceutical Co., Ltd. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Dexmedetomidine Hydrochloride Nasal Spray CI watch — RSS
- Dexmedetomidine Hydrochloride Nasal Spray CI watch — Atom
- Dexmedetomidine Hydrochloride Nasal Spray CI watch — JSON
- Dexmedetomidine Hydrochloride Nasal Spray alone — RSS
Cite this brief
Drug Landscape (2026). Dexmedetomidine Hydrochloride Nasal Spray — Competitive Intelligence Brief. https://druglandscape.com/ci/dexmedetomidine-hydrochloride-nasal-spray. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab